Company Search:
Advanced Search
Sponsored Links
Caladrius Biosciences Inc Company Snapshot
Caladrius Biosciences Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Caladrius Biosciences Inc with three other companies in this sector in the United States: Aratana Therapeutics Inc (2016 sales of $38.55 million ), Jounce Therapeutics Inc ($37.20 million ), and Portola Pharmaceuticals Inc ($35.50 million ).

Sales Analysis. Caladrius Biosciences Inc reported sales of $35.28 million for the year ending December of 2016. This represents an increase of 56.9% versus 2015, when the company's sales were $22.49 million. This was the fourth straight year of sales growth at Caladrius Biosciences Inc. Sales of Pct Segment saw an increase of 57.9% in 2016, from $22.33 million to $35.27 million. Not all segments of Caladrius Biosciences Inc experienced an increase in sales in 2016: sales of R&d Segment fell 90.9% to $14,000.00 . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Caladrius Biosciences Inc
  Stock Performance Chart for Caladrius Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 4.08
(Figures in U.S. Dollars)
1 Week 4.6%   13 Weeks 18.3%  
4 Weeks 11.2%   52 Weeks 5.0%  
Caladrius Biosciences Inc Key Data:
  Ticker: CLBS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 35,283,868
(Year Ending Jan 2017).
Employees: 209
  Currency: U.S. Dollars Market Cap: 38,641,109
  Fiscal Yr Ends: December Shares Outstanding: 9,470,860
  Share Type: Common Closely Held Shares: 2,276,092
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.